Equities

Create Medic Co Ltd

5187:TYO

Create Medic Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)905.00
  • Today's Change1.00 / 0.11%
  • Shares traded10.90k
  • 1 Year change+2.49%
  • Beta0.0686
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CREATE MEDIC CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of medical devices. Its main products include urinary drainage, such as transurethral and nephrostomy; PEG related products; endoscopic products, such as esophagus and stomach; intestinal treatment-devices, such as small intestine and large intestine; anesthesiology products, such as endotracheal tubes and tracheostomy tubes, IVR devices, among others products.

  • Revenue in JPY (TTM)12.93bn
  • Net income in JPY888.98m
  • Incorporated1974
  • Employees962.00
  • Location
    Create Medic Co Ltd2-5-25, Chigasaki-Minami, Tsuzuki-kuYOKOHAMA-SHI 224-0037JapanJPN
  • Phone+81 459432611
  • Websitehttp://www.createmedic.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
KAWAMOTO CORPORATION31.26bn461.69m4.72bn436.009.870.620110.280.150979.6679.665,393.351,267.551.579.203.2471,691,000.002.134.034.037.7117.3017.791.362.371.3525.060.44511.19-2.544.66-46.2541.6216.7435.10
Kowa Co Ltd6.39bn726.57m4.80bn213.005.891.535.030.7506162.57162.571,414.88623.861.242.825.8729,992,250.0014.386.0623.339.1045.6846.3711.625.391.1013.550.276222.732.167.1962.08---10.57--
Data Horizon Co Ltd4.91bn-901.84m5.08bn374.00--1.76--1.04-71.15-71.15387.43226.700.699818.213.3813,130,090.00-13.14-8.40-20.33-12.1327.9039.93-18.77-7.731.17-46.560.5284--13.5317.28-21.41--64.50--
KAINOS Laboratories, Inc.5.24bn615.86m5.45bn146.008.170.77927.491.04146.29146.291,244.141,533.730.6323.243.2835,882,720.007.436.929.219.2650.1851.8411.7610.803.11--0.078419.622.711.6012.2810.57-9.8316.36
Aso International Inc3.60bn421.09m5.51bn276.0013.352.0614.551.5384.5284.52721.30546.461.2514.527.6513,039,030.0014.61--16.47--44.72--11.70--7.5939.33----11.12--14.27------
Yamashita Health Care Holdings Inc62.72bn501.00m5.65bn606.0011.180.64857.840.09197.83197.8324,816.183,411.072.6417.765.65103,493,400.002.112.235.746.4513.7412.460.79720.84721.01--0.0033.155.770.0071164.8432.063.8410.76
Leoclan Co Ltd19.80bn136.06m5.75bn176.0042.421.0322.630.290322.9622.963,346.78943.511.56368.493.41--1.222.192.384.8213.2210.820.78041.172.40-------25.64-11.32-49.85-28.60-19.34--
Precision System Science Co., Ltd.3.98bn-1.12bn7.39bn158.00--1.78--1.86-40.59-40.59144.04149.930.49261.585.4625,189,580.00-13.88-3.81-18.40-5.0923.8830.40-28.18-5.531.49-16.260.2488---24.60-1.9015.31---24.26--
Koken Ltd10.22bn565.86m7.90bn287.0013.510.60787.800.7729114.49114.492,066.952,545.070.49912.003.0135,597,010.002.763.703.414.7545.6946.695.547.191.8122.340.306825.88-0.16054.92-15.8414.33-39.876.96
Create Medic Co Ltd12.93bn888.98m8.75bn962.009.050.51955.690.6765100.05100.051,446.831,742.180.68071.724.6413,440,170.004.683.005.453.5343.7645.366.884.603.47--0.050663.222.103.11-68.06-25.530.66271.12
DVx Inc47.25bn55.70m9.55bn316.00166.261.0520.400.20215.335.334,522.33842.242.0623.294.13149,530,700.000.24323.110.58267.5710.2211.600.11791.491.42----47.57-3.442.57-81.53-29.2311.2315.81
EcoNaviSta Inc1.20bn281.96m10.77bn35.0042.313.3335.648.9838.6538.65170.53490.670.38961.5218.3634,260,280.009.16--9.85--66.17--23.51--15.45--0.00--21.55--38.02------
JMS Co Ltd67.87bn-36.00m10.93bn5.28k--0.26782.870.1611-1.47-1.472,772.011,650.800.82132.643.8012,847,620.00-0.05081.33-0.07381.9721.9524.29-0.06191.571.070.68320.383243.312.432.38-112.81---2.421.22
OLBA Healthcare Holdings Inc120.11bn1.50bn12.57bn1.35k7.951.086.040.1046252.91252.9120,250.401,863.862.8316.304.8088,710,020.003.533.0011.8910.3711.5011.291.251.040.9459742.060.21432.627.331.996.0914.11-2.5814.87
Data as of Nov 15 2024. Currency figures normalised to Create Medic Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

1.61%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 03 Oct 202446.40k0.48%
Dimensional Fund Advisors LPas of 31 Jul 202433.30k0.35%
Nikko Asset Management Co., Ltd.as of 04 Oct 202422.30k0.23%
Daiwa Asset Management Co. Ltd.as of 30 Sep 202421.40k0.22%
Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Oct 20248.80k0.09%
Allspring Global Investments LLCas of 31 Oct 20245.68k0.06%
Dimensional Fund Advisors Ltd.as of 31 Aug 20245.39k0.06%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 19 Feb 20245.30k0.06%
BlackRock Japan Co. Ltd.as of 03 Oct 20243.60k0.04%
Asset Management One Co., Ltd.as of 03 Oct 20243.20k0.03%
More ▼
Data from 30 Jun 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.